SavedAdd your journal

Journals / Göztepe Tıp Dergisi / 2003 / Cilt: 18 - Sayı: 2

Vima method with sevoflurane in a case with myastenia graves

Miyasteniya gravis'te sevofluran ile vima yöntemi

Reyhan FİDAN
Melek ÇELİK
Esra SAĞIROĞLU
N. Ali ÖZÇEKİÇ
Pages
121–123
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Inhalational agents can be used for anaesthetic induction of myasthenics with the advantage of avoiding the use of neuromuscular blocking agents.In this study, we present a myasthenic case, for her umblical hernia operation in which sevoflurane was used in induction and in maintainence of anaesthesia as a single agent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Myasthenia gravis is an autoimmune disease, resulting from the production of antibodies against the acetylcholine receptors of the neuromuscular endplate.
📊
Key Findings & Data:These antibodies reduce the active receptors, brought about either by functional block of the receptors, by increased rate of receptor degration, or by complement-mediated lysis.
💡
Conclusion & Impact:Inhalational agents can be used for anaesthetic induction of myasthenics with the advantage of avoiding the use of neuromuscular blocking agents.In this study, we present a myasthenic case, for her umblical hernia operation in which sevoflurane was used in induction and in maintainence of anaesthesia as a single agent.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Myasthenia gravis is an autoimmune disease, resulting from the production of antibodies against the acetylcholine receptors of the neuromuscular endplate. These antibodies reduce the active receptors, brought about either by functional block of the receptors, by increased rate of receptor degration, or by complement-mediated lysis. Myasthenic patients are special for anaesthesia. The myasthenic patient may demonstrate an abnormal neuromuscular response to both depolarizing and nondepolarizing muscle relaxans. Volatil induction and maintenance was successfully employed for patients without myo-pathy. Inhalational agents can be used for anaesthetic induction of myasthenics with the advantage of avoiding the use of neuromuscular blocking agents.In this study, we present a myasthenic case, for her umblical hernia operation in which sevoflurane was used in induction and in maintainence of anaesthesia as a single agent.

🔖

Cite This Article

FİDAN, R., ÇELİK, M., SAĞIROĞLU, E., ÖZÇEKİÇ, N. A. (2022). Vima method with sevoflurane in a case with myastenia graves. Göztepe Tıp Dergisi, Cilt: 18 - Sayı: 2, 121–123. https://ajindex.com/articles/526516

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Cotran R, Kumar V, Robbiııs S: Robbins pathologic basis of disease. 4th edition, Saunders Company USA 1366-1367, 1989
  2. Baraka A: Anaesthesia and myasthenia gravis: Can J Anaesth 39:476-86. 1992
  3. Osserman KE, Genkins G: Review of a twenty-year exrerience in over 1200 patients. M Sinai J M 38:497-537, 1971
  4. Leventhal SR, Orkin FK, Hirslı RA: Prediction of the need of postoperative mechanical ventilation in myasthenia gravis. Anaesthesiology 52:26-30, 1980
  5. Orkin FK, Leventhal SR, Hirslı RA: Predicting respiratory failure following thymectomy. Ann NY Acad Sci 377:862-3. 1981
  6. Grant RP, Jenkins LC: Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymeclomy comparedd to otlier surgical procedures. Can Anaesth Soc J 29:112. 1982
  7. Katz J,:Benumof J, Kadis L: Anesthesia and uncommon disease. 3th edition. Saunders Company USA 615-620, 1990
  8. Bell CF, Florence AM, Hunter JM, ct al: Atracurium in the myasthenic patient. Anaesthesia 39(10):961-8, 1984
  9. Smith CE, Donati F, Bevan DR: Cumulative dose-response curves for atracurium in patients with myasthenia gravis. Can J Anaesth 36(4):402-6, 1989
  10. Wakz R, Lubbe N, Walz K, ct al: Muscle relaxation with atracurium in myasthenia gravis:Anaesthesiol Reanim 21 (2):43-6. 1996
  11. Eisenkraft JB, Book WJ, Papatestas AE: Sensitivity to vecuronium in myasthenia gravis: a dose response study. Can J Anaesth 37(3):301 -6, 1990
  12. Nilsson E, Meretoja OA: Vecuronium dose-response and maintenance requirements in patients with myasthenia gravis. Anesthesioiogy 73(l):28-32, 1990
  13. Baraka A, Siddik S, Kawkabani N: Cisatracurium in myasthenic patient undergoing thymectomy. Can J Anaesth 46(8):779-82, 1999
  14. Seigne RD, Scott RPF: Mivacurium chloride end myasthenia gravis. Br J Anaesth 72:468-9. 1994
  15. Ruiz-Neto PP, Halpern H, Crcmoncsi E: Rapid inhalation induction with halothane-nitrous oxide for myasthenic patients. Can J Anaesth 41 (2): 102-6. 1994
  16. Kiran U, Choudhury M, Saxena N, et nl: Sevoflunme as a sole anaesthetic for thymeclomy in myastlienia gravis. Acta Anaesthesiol Scand 44(3):351 -3,2000
  17. Lin CC, Chen MF, Chen HM, ct al: Propofol anesthesia in a patient with myasthenia gravis-a case report. Acta Anaesthesiol Sin 34(2):89-92, 1996
  18. Lorimer M, Hall R: Remifentanil and propofol total intravenous anaesthesia for thymectoniy in myasthenia gravis. Anaesth Intensive Care 268(2):2l0-2. 1998.